PHAON DUNBAR: Open Payments
NPI 1497418370 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 22 payments from 14 companies in 2025. Trend: 2023 $580 · 2024 $513 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Daiichi Sankyo Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| SERVIER PHARMACEUTICALS LLC | 2 | $32 |
| SOBI, INC | 1 | $28 |
| GENZYME CORPORATION | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $24 |
| Incyte Corporation | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: DATROWAY, KEYTRUDA, IBRANCE, Tibsovo, KISQALI, Doptelet, SCEMBLIX, SARCLISA.
Industry payments across LA — which companies pay providers there.
